Acetaminophen

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

115 Suppliers, 84 USDMF, 20 CEP/COS, 16 JDMF, 7 EU WC, 111 KDMF, 105 NDC API, 24 Listed Suppliers

DEVELOPMENTS

32 Drug(s) in Development

32 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

2396 Dossiers, 722 FDA Orange Book, 486 Europe, 293 Canada, 105 Australia, 381 South Africa, 409 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML), TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

Suppliers, 56 Roquette, 44 BASF, 39 Kerry, 27 Microlex e.U, 22 Seppic, 22 Nanjing Well Pharmaceutical, 20 SPI Pharma, 19 Actylis, 17 Gangwal Chemicals, 16 Gangwal Healthcare, 13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 Corel Pharma Chem, 12 Boai NKY Pharmaceuticals Ltd, 12 Sigachi Industries, 11 Rochem International Inc, 8 DKSH, 8 Beneo, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Ideal Cures Pvt Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 6 Clariant, 5 Pharmatrans-Sanaq, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Vasa Pharmachem, 4 ACG Worldwide, 4 Alcedo Pharmachem, 4 Finar, 4 The Dow Chemical Company, 4 Ulanqab Kema New Material, 3 Kima Chemical, 3 Shijiazhuang Huaxu Pharmaceutical, 3 Aeon Procare, 3 Jai Radhe Sales, 3 Zhejiang Huakang Pharmaceutical, 2 Bioplus Life Sciences, 2 Qualicaps, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Minakem, 2 Nomisma Healthcare, 2 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas

EXCIPIENTS BY APPLICATIONS

124 Fillers, Diluents & Binders, 66 Solubilizers, 63 Coating Systems & Additives, 60 Thickeners and Stabilizers, 57 Taste Masking, 52 Direct Compression, 48 Topical, 48 Disintegrants & Superdisintegrants, 42 Parenteral, 41 Controlled & Modified Release, 39 Lubricants & Glidants, 38 Film Formers & Plasticizers, 35 Granulation, 23 Chewable & Orodispersible Aids, 19 Emulsifying Agents, 18 Co-Processed Excipients, 12 Surfactant & Foaming Agents, 12 API Stability Enhancers, 9 Empty Capsules, 8 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 381 Finished Drug Prices

MARKET PLACE

161 APIs, 92 DOSSIERS // FDF

PATENTS

40 US Patents, 2 US Exclusivities, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 8 Analytical Solutions, 1 EDQM Standards, 7 USP Standards, 1 JP Standards, 21 Other Ref. Standards

DIGITAL CONTENT

10 Data Compilation & Company Tracker #PharmaFlow, 320 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Acetaminophen

Acetaminophen

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

115 Suppliers

84 USDMF

20 CEP/COS

16 JDMF

7 EU WC

111 KDMF

105 NDC API

24 Listed Suppliers

DEVELOPMENTS

32 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

2396 Dossiers

722 FDA Orange Book

486 Europe

293 Canada

105 Australia

381 South Africa

409 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUPPOSITORY;RECTAL - 120MG

SUPPOSITORY;RECTAL - 325MG

SUPPOSITORY;RECTAL - 650MG

SUPPOSITORY;RECTAL - 80MG

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 325MG;37.5MG

SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML)

TABLET;ORAL - 300MG;15MG

TABLET;ORAL - 300MG;30MG

TABLET;ORAL - 300MG;60MG

TABLET;ORAL - 325MG;5MG

TABLET;ORAL - 325MG;50MG;40MG

TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

Suppliers

56 Roquette

44 BASF

39 Kerry

27 Microlex e.U

22 Seppic

22 Nanjing Well Pharmaceutical

20 SPI Pharma

19 Actylis

17 Gangwal Chemicals

16 Gangwal Healthcare

13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

12 Corel Pharma Chem

12 Boai NKY Pharmaceuticals Ltd

12 Sigachi Industries

11 Rochem International Inc

8 DKSH

8 Beneo

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Ideal Cures Pvt Ltd

7 DFE Pharma

6 Lonza Capsugel

6 Clariant

5 Pharmatrans-Sanaq

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Vasa Pharmachem

4 ACG Worldwide

4 Alcedo Pharmachem

4 Finar

4 The Dow Chemical Company

4 Ulanqab Kema New Material

3 Kima Chemical

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons